Study with Riociguat (BAY 63-2521) in patients with pulmonary hypertension associated with left heart failure

Update Il y a 4 ans
Reference: EUCTR2009-015878-35

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to assess the hemodynamic profile of Riociguat in patients with symptomatic pulmonary hypertension associated with left ventricular systolic dysfunction (PH-sLVD).


Inclusion criteria

  • Patients symptomatic with pulmonary hypertension associated with left ventricular systolic dysfunction (PH-sLVD)